In spite of NeoGenomics Inc.’s (NASDAQ:NEO) recent upswing, most analysts remain bearish.

In the latest session, NeoGenomics Inc. (NASDAQ: NEO) closed at $10.25 up 0.79% from its previous closing price of $10.17. In other words, the price has increased by $+0.08 from its previous closing price. On the day, 748754 shares were traded. NEO stock price reached its highest trading level at $10.28 during the session, while it also had its lowest trading level at $9.82.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

For a deeper understanding of NeoGenomics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.80 and its Current Ratio is at 7.10. In the meantime, Its Debt-to-Equity ratio is 0.53 whereas as Long-Term Debt/Eq ratio is at 0.53.

Upgrades & Downgrades

On June 03, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $13.Piper Sandler initiated its Overweight rating on June 03, 2022, with a $13 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 when Bonello William sold 3,209 shares for $18.29 per share. The transaction valued at 58,693 led to the insider holds 98,516 shares of the business.

McKenzie Kathryn B sold 1,846 shares of NEO for $64,610 on Dec 21. The Chief Financial Officer now owns 11,689 shares after completing the transaction at $35.00 per share. On Dec 06, another insider, Mallon Mark, who serves as the Chief Executive Officer of the company, bought 17,000 shares for $30.63 each. As a result, the insider paid 520,710 and bolstered with 72,736 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.56 while its Price-to-Book (P/B) ratio in mrq is 1.26.

Stock Price History:

Over the past 52 weeks, NEO has reached a high of $40.54, while it has fallen to a 52-week low of $6.00. The 50-Day Moving Average of the stock is 8.64, while the 200-Day Moving Average is calculated to be 11.25.

Shares Statistics:

For the past three months, NEO has traded an average of 1.25M shares per day and 1.75M over the past ten days. A total of 124.42M shares are outstanding, with a floating share count of 122.24M. Insiders hold about 1.00% of the company’s shares, while institutions hold 91.30% stake in the company. Shares short for NEO as of Oct 13, 2022 were 5.39M with a Short Ratio of 5.57M, compared to 4M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.28% and a Short% of Float of 5.91%.

Earnings Estimates

There are 13 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.25, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.12 and low estimates of -$0.22.

Analysts are recommending an EPS of between -$0.63 and -$0.83 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$0.54, with 13 analysts recommending between -$0.17 and -$0.82.

Revenue Estimates

A total of 13 analysts have provided revenue estimates for NEO’s current fiscal year. The highest revenue estimate was $495.72M, while the lowest revenue estimate was $482.34M, resulting in an average revenue estimate of $490.28M. In the same quarter a year ago, actual revenue was $484.33M, up 1.20% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $534.29M in the next fiscal year. The high estimate is $557.3M and the low estimate is $515.3M. The average revenue growth estimate for next year is up 9.00% from the average revenue estimate for this year.